#FutureReadyHealthcare
Educating HCPs and raising awareness to patients (~57million women in the US affected by POP) about the product’s unique benefits
Finding a single partner with expertise that provides end-to-end services from clinical to Rx and post-launch vigilance
Limited in-house expertise on clinical, regulatory, safety, medical affairs, and commercialization processes to plan, scale up and accelerate launch operations across the US
End-to-end co-commercialization with shared risk and investment
A flexible commercial model for an equitable share of commercial value
A committed team with life sciences expertise, a digital-first approach, and a high touch engagement model
An accelerated path to meet 60 million devices per year peak sales run-rate
Trust in a qualified partner committed to advance the company’s mission to empower women suffering from POP
Devices per year target
In advancing company’s mission
Across the value chain
© 2023 Indegene. All Rights Reserved.